Skip to content
healthcare.dev
Get a free key

SIVEXTRO

NDC 67919-040, tedizolid phosphate, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.

Product NDC
67919-040
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67919-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEDIZOLID PHOSPHATE200 mg/4mL

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]

Package NDCNDC-11Package
67919-040-026791900400210 VIAL, GLASS in 1 CARTON (67919-040-02) / 4 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/75672079-589f-451a-bdbf-eaebcfcc80a9

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67919-040

Use it

Look up 67919-040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67919-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67919-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.